MHC
PFE icon

May Hill Capital’s Pfizer PFE Stock Holding History

May Hill Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
9,343
-2,842
-23% -$74.3K 0.05% 228
2026
Q1 		$342K Buy
12,185
+2,997
+33% +$79.8K 0.09% 162
2025
Q4 		$229K Sell
9,188
-23
-0.2% -$580 0.06% 179
2025
Q3 		$235K Buy
+9,211
New +$227K 0.07% 170

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

May Hill Capital's PFE Position: Q2 2026 in Review

May Hill Capital reduced its Pfizer (PFE) stake by 23% in Q2 2026, selling an estimated $74.3K and leaving 9,343 shares worth $225K. The position accounts for 0.05% of the portfolio, ranked #228.

May Hill Capital first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $342K in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • May Hill Capital held 9,343 shares of Pfizer worth $225K as of Q2 2026.
  • May Hill Capital sold 2,842 Pfizer shares in Q2 2026, an estimated $74.3K.
  • Pfizer made up 0.05% of May Hill Capital's portfolio in Q2 2026, its #228 holding.
  • May Hill Capital first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • May Hill Capital's Pfizer position peaked at $342K in Q1 2026.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.